Multiple Biologics Treatment Failures in Patients with Psoriasis: A Case Series of 4 Patients

Multiple Biologics Treatment Failures in Patients with Psoriasis: A Case Series of 4 Patients

Saved in:

Bibliographic Details
Main Authors:	Mikkel Bak Jensen, Nikolai Loft, Claus Zachariae, Lone Skov
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-03-01
Series:	Acta Dermato-Venereologica
Subjects:	Psoriasis Biologics JAK inhibitors Biomarkers Therapy
Online Access:	https://medicaljournalssweden.se/actadv/article/view/42987
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sex Differences in Dermatology Life Quality Index (DLQI) among Patients with Psoriasis
by: Mikkel Bak Jensen, et al.
Published: (2024-12-01)

Abrocitinib Treatment for Localized Type of Generalized Pustular Psoriasis: A Case Report
by: Yang Z, et al.
Published: (2025-03-01)

Case Report: Effectiveness of deucravacitinib in chronic recurrent multifocal osteomyelitis and concomitant psoriasis
by: Caroline Glatzel, et al.
Published: (2025-05-01)

New-onset psoriasis with abrocitinib therapy for atopic dermatitis
by: Sarah L. Becker, BA, et al.
Published: (2025-07-01)

Efficacy and Duration of Biological Therapies among Saudi Patients with Psoriasis
by: Sami N. Alsuwaidan, et al.
Published: (2024-12-01)

Successful treatment of a case of dupilumab-induced psoriasis and alopecia areata with tofacitinib
by: SUN Feifei, et al.
Published: (2025-06-01)

Risk of infections during treatment with oral Janus kinase inhibitors in randomized placebo-controlled trials: A systematic review and meta-analysisCapsule Summary
by: Daniel Isufi, BSc(Med), et al.
Published: (2025-02-01)

Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes
by: Bruce E. Strober, et al.
Published: (2025-05-01)

Role of methotrexate in biologics use with psoriasis and psoriatic arthritis
by: Ting-Ting Cheng, et al.
Published: (2025-04-01)

Assessment of TNF-α, IL-12/23, and IL-17 in Psoriasis: Only TNF-α Reflects Clinical Response After 12 Weeks of Biologic Treatment
by: Alessandra-Mădălina Matei-Man, et al.
Published: (2025-05-01)

Biological therapy in the reduction of cardiovascular risk in patients with psoriasis
by: Andrés Tirado-Sánchez
Published: (2025-01-01)

Bibliometric analysis and description of research trends in the treatment of psoriasis with biologic agents in the past two decades (2004–2023)
by: Yingdong Wang, et al.
Published: (2024-12-01)

Real-world experience with brodalumab in a Portuguese cohort of patients with moderate-to-severe psoriasis
by: Tiago Torres, et al.
Published: (2025-03-01)

Sex-disparities in pediatric and young adult patients with psoriasis treated with biologics: differences in adverse events and disease activity
by: Malak Al-Gawahiri, et al.
Published: (2025-12-01)

Ustekinumab Efficacy in Children with Palmoplantar Psoriasis: Case Series
by: Maria A. Leonova, et al.
Published: (2024-11-01)

The marked and rapid therapeutic effect of tofacitinib in combination with subcutaneous methotrexate in a rheumatoid arthritis patient with poor prognostic factors who is resistant to standard disease-modifying antirheumatic drugs and biologicals: A clinical case
by: N. V. Demidova, et al.
Published: (2016-03-01)

A tryptophol-containing emulgel ameliorates imiquimod-induced mice psoriasis
by: Arnon Pudgerd, et al.
Published: (2025-06-01)

Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis
by: Ma L, et al.
Published: (2025-04-01)

Demographics, Clinical Characteristics, and Treatment Patterns in Patients with Psoriasis: Insights from the Saudi Arabia Psoriasis Registry (PSORSA)
by: Mohammad Ibrahim Fatani, et al.
Published: (2025-05-01)

Breakthrough Psoriasis in Patients Receiving Biologicals
by: Damsin T, et al.
Published: (2025-01-01)

Novel Approach for Evaluating the Effectiveness of Biological Drugs in Patients with Plaque Psoriasis: Real-World Experience of a Single-Centre Study in Poland
by: Kimak-Pielas A, et al.
Published: (2025-06-01)

Infection Risk and Vaccination in the Management of Psoriasis: Considerations for Biologic Therapy
by: Mateu-Arrom L, et al.
Published: (2025-04-01)

Latent tuberculosis infection in patients with psoriasis using biologic therapies
by: Fernanda Luiza Staub, et al.
Published: (2025-06-01)

COVID-19 pandemic and vaccination rate in patients with psoriasis treated with biologics: A single center experience
by: Milčić Danijela, et al.
Published: (2024-01-01)

Patient-centred Preferences for Biologic Therapies in Moderate to Severe Psoriasis in Vietnam: A Discrete Choice Experiment
by: Chuyen Thi Hong Nguyen, et al.
Published: (2025-05-01)

Long-term effectiveness and safety of risankizumab in patients with moderate-to-severe psoriasis with and without cardiometabolic comorbidities: a single-center retrospective study
by: Luciano Ibba, et al.
Published: (2024-12-01)

Can the development of psoriatic arthritis be prevented in patients with psoriasis?
by: E. L. Nasonov, et al.
Published: (2019-07-01)

Complete treatment experience on psoriasis patients with secukinumab in real practice in Krasnodar region
by: L. S. Kruglova, et al.
Published: (2021-06-01)

Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022
by: Jiao Wang, et al.
Published: (2025-02-01)

Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan
by: Celine Miyazaki, et al.
Published: (2024-12-01)

Effective treatment of recalcitrant palmoplantar psoriasis in a patient with skin of color using bimekizumab
by: Emily G. Tocco, BS, et al.
Published: (2025-09-01)

Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01)

Prescribing patterns and persistence of biological therapies for psoriasis management: a retrospective cohort study from Saudi Arabia
by: Ahmad Alamer, et al.
Published: (2024-12-01)

Immunogenicity induced by biologicals in the treatment of psoriasis and psoriatic arthritis: View of the problem
by: T. V. Korotaeva
Published: (2016-01-01)

Medical and social care program for patients with psoriasis and/or psoriatic arthritis eligible for biological dmards in real clinical practice
by: L. S. Kruglova, et al.
Published: (2020-11-01)

Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series
by: Andrea D'Arino, et al.
Published: (2025-07-01)

Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2024-12-01)

Case Report: Cutaneous T-cell lymphoma associated with biologic therapy: three cases and a literature review
by: Tingting Li, et al.
Published: (2025-04-01)

The Emerging World of JAK Inhibitors
by: Shraddha Uprety
Published: (2024-10-01)

The Emerging World of JAK Inhibitors
by: Shraddha Uprety
Published: (2024-10-01)